Header

UZH-Logo

Maintenance Infos

Publications for Rechsteiner, M

Navigate back| Up a level
Export as
Group by:
Number of items: 32.

2019

Rupp, Niels J; Brada, Muriel; Skálová, Alena; Bode, Beata; Broglie, Martina A; Morand, Grégoire B; Rechsteiner, Markus; Freiberger, Sandra N (2019). New Insights into Tumor Heterogeneity: A Case of Solid-Oncocytic Epithelial-Myoepithelial Carcinoma of the Parotid Gland Harboring a HRAS and Heterogeneous Terminating ARID1A Mutation. Head and neck pathology:Epub ahead of print.

Corrò, Claudia; Healy, Marc E; Engler, Stefanie; Bodenmiller, Bernd; Li, Zhe; Schraml, Peter; Weber, Achim; Frew, Ian J; Rechsteiner, Markus; Moch, Holger (2019). IL-8 and CXCR1 expression is associated with cancer stem cell-like properties of clear cell renal cancer. Journal of Pathology, 248(3):377-389.

Bolck, Hella A; Corrò, Claudia; Kahraman, Abdullah; von Teichman, Adriana; Toussaint, Nora C; Kuipers, Jack; Chiovaro, Francesca; Koelzer, Viktor H; Pauli, Chantal; Moritz, Wolfgang; Bode, Peter K; Rechsteiner, Markus; Beerenwinkel, Niko; Schraml, Peter; Moch, Holger (2019). Tracing Clonal Dynamics Reveals that Two- and Three-dimensional Patient-derived Cell Models Capture Tumor Heterogeneity of Clear Cell Renal Cell Carcinoma. European Urology Focus:759.

Leblond, Anne-Laure; Rechsteiner, Markus; Jones, Amy; Brajkovic, Saska; Dupouy, Diego; Soltermann, Alex (2019). Microfluidic-Based Immunohistochemistry Combined With Next-Generation Sequencing on Diagnostic Tissue Sections for Detection of Tumoral BRAF V600E Mutation. American Journal of Clinical Pathology, 152(1):59-73.

Dimitriou, Florentia; Mangana, Joanna; Curioni-Fontecedro, Alessandra; Rechsteiner, Markus; Turko, Patrick; Braun, Ralph P; Dummer, Reinhard; Cheng, Phil F (2019). Melanoma patients with additional primary cancers: a single-center retrospective analysis. OncoTarget, 10(36):3373-3384.

Wyvekens, Nicolas; Rechsteiner, Markus; Fritz, Christine; Wagner, Ulrich; Tchinda, Joëlle; Wenzel, Carina; Kuithan, Friederike; Horn, Lars-Christian; Moch, Holger (2019). Histological and molecular characterization of TFEB-rearranged renal cell carcinomas. Virchows Archiv, 474(5):625-631.

Grosse, Alexandra; Grosse, Claudia; Rechsteiner, Markus; Soltermann, Alex (2019). Analysis of the frequency of oncogenic driver mutations and correlation with clinicopathological characteristics in patients with lung adenocarcinoma from Northeastern Switzerland. Diagnostic Pathology, 14(1):18.

2018

Rupp, Niels J; Rechsteiner, Markus; Freiberger, Sandra N; Lenggenhager, Daniela; Urosevic, Mirjana; Burger, Irene A; Rushing, Elisabeth J; Mihic-Probst, Daniela (2018). New observations in tumor cell plasticity: mutational profiling in a case of metastatic melanoma with biphasic sarcomatoid transdifferentiation. Virchows Archiv, 473(4):517-521.

Zhong, Qing; Wagner, Ulrich; Kurt, Henriette; Molinari, Francesca; Cathomas, Gieri; Komminoth, Paul; Barman-Aksözen, Jasmin; Schneider-Yin, Xiaoye; Rey, Jean-Philippe; Vassella, Erik; Rogel, Uwe; Diebold, Joachim; McKee, Thomas; Jochum, Wolfram; Kashofer, Karl; Hofman, Paul; Zischka, Melanie; Moch, Holger; Rechsteiner, Markus; Wild, Peter J (2018). Multi-laboratory proficiency testing of clinical cancer genomic profiling by next-generation sequencing. Pathology, Research and Practice, 214(7):957-963.

Rechsteiner, Markus; Dedes, Konstantin; Fink, Daniel; Pestalozzi, Bernhard; Sobottka, Bettina; Moch, Holger; Wild, Peter; Varga, Zsuzsanna (2018). Somatic BRCA1 mutations in clinically sporadic breast cancer with medullary histological features. Journal of Cancer Research and Clinical Oncology, 144(5):865-874.

2017

Corrò, Claudia; Hejhal, Tomas; Poyet, Cédric; Sulser, Tullio; Hermanns, Thomas; Winder, Thomas; Prager, Gerald; Wild, Peter J; Frew, Ian; Moch, Holger; Rechsteiner, Markus (2017). Detecting circulating tumor DNA in renal cancer: An open challenge. Experimental and Molecular Pathology, 102(2):255-261.

Zhong, Qing; Guo, Tiannan; Rechsteiner, Markus; Rüschoff, Jan H; Rupp, Niels; Fankhauser, Christian; Saba, Karim; Mortezavi, Ashkan; Poyet, Cédric; Hermanns, Thomas; Zhu, Yi; Moch, Holger; Aebersold, Ruedi; Wild, Peter J (2017). A curated collection of tissue microarray images and clinical outcome data of prostate cancer patients. Scientific Data, 4:170014.

Razafinjatovo, Caroline Fanja; Stiehl, Daniel; Deininger, Eva; Rechsteiner, Markus; Moch, Holger; Schraml, Peter (2017). VHL missense mutations in the p53 binding domain show different effects on p53 signaling and HIFα degradation in clear cell renal cell carcinoma. OncoTarget, 8(6):10199-10212.

Valtcheva, Nadejda; Lang, Franziska M; Noske, Aurelia; Samartzis, Eleftherios P; Schmidt, Anna-Maria; Bellini, Elisa; Fink, Daniel; Moch, Holger; Rechsteiner, Markus; Dedes, Konstantin J; Wild, Peter J (2017). Tracking the origin of simultaneous endometrial and ovarian cancer by next-generation sequencing - a case report. BMC Cancer, 17(1):1-9.

2016

Zhong, Qing; Rüschoff, Jan H; Guo, Tiannan; Gabrani, Maria; Schüffler, Peter J; Rechsteiner, Markus; Liu, Yansheng; Fuchs, Thomas J; Rupp, Niels J; Fankhauser, Christian; Buhmann, Joachim M; Perner, Sven; Poyet, Cédric; Blattner, Miriam; Soldini, Davide; Moch, Holger; Rubin, Mark A; Noske, Aurelia; Rüschoff, Josef; Haffner, Michael C; Jochum, Wolfram; Wild, Peter J (2016). Image-based computational quantification and visualization of genetic alterations and tumour heterogeneity. Scientific Reports, 6:24146.

Friemel, Juliane; Rechsteiner, Markus; Bawohl, Marion; Frick, Lukas; Müllhaupt, Beat; Lesurtel, Mickaël; Weber, Achim (2016). Liver cancer with concomitant TP53 and CTNNB1 mutations: a case report. BMC Clinical Pathology, 16:7.

Rupp, Niels J; Schüffler, Peter J; Zhong, Qing; Falkner, Florian; Rechsteiner, Markus; Rüschoff, Jan H; Fankhauser, Christian; Drach, Matthias; Largo, Remo; Tremp, Mathias; Poyet, Cedric; Sulser, Tullio; Kristiansen, Glen; Moch, Holger; Buhmann, Joachim; Müntener, Michael; Wild, Peter J (2016). Oxygen supply maps for hypoxic microenvironment visualization in prostate cancer. Journal of Pathology Informatics, 7:3.

Frauchiger, A L; Mangana, J; Rechsteiner, M; Moch, H; Seifert, Burkhardt; Braun, R; Dummer, R; Goldinger, S M (2016). Prognostic relevance of LDH and serum S-100 levels in Stage IV melanoma with known BRAF mutation status. British Journal of Dermatology, 174(4):823-830.

2015

Albers, Joachim; Danzer, Claudia; Rechsteiner, Markus; Lehmann, Holger; Brandt, Laura P; Hejhal, Tomas; Catalano, Antonella; Busenhart, Philipp; Gonçalves, Ana Filipa; Brandt, Simone; Bode, Peter K; Bode-Lesniewska, Beata; Wild, Peter J; Frew, Ian J (2015). A versatile modular vector system for rapid combinatorial mammalian genetics. Journal of Clinical Investigation, 125(4):1603-1619.

Rechsteiner, M; Wild, P; Kiessling, M K; Bohnert, A; Zhong, Q; Stahel, R A; Moch, H; Curioni-Fontecedro, A (2015). A novel germline mutation of PDGFR-β might be associated with clinical response of colorectal cancer to regorafenib. Annals of Oncology, 26(1):246-248.

Mangana, Joanna; Cheng, Phil F; Schindler, Katja; Weide, Benjamin; Held, Ulrike; Frauchiger, Anna L; Romano, Emanuella; Kähler, Katharina C; Rozati, Sima; Rechsteiner, Markus; Moch, Holger; Michielin, Olivier; Garbe, Claus; Hauschild, Axel; Hoeller, Christoph; Dummer, Reinhard; Goldinger, Simone M (2015). Analysis of BRAF and NRAS mutation status in advanced melanoma patients treated with anti-CTLA-4 antibodies: association with overall survival? PLoS ONE, 10(10):e0139438.

2014

Ikenberg, Kristian; Valtcheva, Nadejda; Brandt, Simone; Zhong, Qing; Wong, Christine E; Noske, Aurelia; Rechsteiner, Markus; Rueschoff, Jan H; Caduff, Rosmarie; Dellas, Athanassios; Obermann, Ellen; Fink, Daniel; Fuchs, Thomas; Krek, Wilhelm; Moch, Holger; Frew, Ian J; Wild, Peter J (2014). KPNA2 is overexpressed in human and mouse endometrial cancers and promotes cellular proliferation. Journal of Pathology, 234(2):239-252.

Rechsteiner, Markus; Müller, Rouven; Reineke, Tanja; Goede, Jeroen; Bohnert, Annette; Zhong, Qing; Manz, Markus G; Moch, Holger; Wild, Peter J; Zimmermann, Dieter R; Tinguely, Marianne (2014). Modelling of a genetically diverse evolution of Systemic Mastocytosis with Chronic Myelomonocytic Leukemia (SM-CMML) by next generation sequencing. Experimental Hematology & Oncology, 3:18.

2013

Rechsteiner, Markus; von Teichman, Adriana; Rüschoff, Jan H; Fankhauser, Niklaus; Pestalozzi, Bernhard; Schraml, Peter; Weber, Achim; Wild, Peter; Zimmermann, Dieter; Moch, Holger (2013). KRAS, BRAF, and TP53 deep-sequencing for colorectal carcinoma patient diagnostics. Journal of Molecular Diagnostics, 15(3):299-311.

Wild, Peter J; Zhong, Qing; Zimmermann, Dieter R; Rechsteiner, Markus; Fritz, Christine; Valtcheva, Nadejda; Moch, Holger (2013). Personalisierte Krebsmedizin und die Zukunft der Pathologie. info@onkologie, 6:9-12.

Rechsteiner, Markus; Zimmermann, Anne-Katrin; Wild, Peter J; Caduff, Rosmarie; von Teichman, Adriana; Fink, Daniel; Moch, Holger; Noske, Aurelia (2013). TP53 mutations are common in all subtypes of epithelial ovarian cancer and occur concomitantly with KRAS mutations in the mucinous type. Experimental and Molecular Pathology, 95(2):235-241.

Casagrande, Silvia; Ruf, Melanie; Rechsteiner, Markus; Morra, Laura; Brun-Schmid, Sonja; von Teichman, Adriana; Krek, Wilhelm; Schraml, Peter; Moch, Holger (2013). The Protein-Tyrosine Phosphatase Receptor Type J is regulated by the pVHL-HIF axis in Clear Cell Renal Cell Carcinoma. Journal of Pathology, 229(4):525-534.

2012

Morra, L; Rechsteiner, M; Casagrande, S; von Teichman, A; Schraml, P; Moch, H; Soltermann, A (2012). Characterization of periostin isoform pattern in non-small cell lung cancer. Lung Cancer, 76(2):183-190.

Gerstung, Moritz; Beisel, Christian; Rechsteiner, Markus; Wild, Peter; Schraml, Peter; Moch, Holger; Beerenwinkel, Niko (2012). Reliable detection of subclonal single-nucleotide variants in tumour cell populations. Nature Communications, 3:811.

Wild, Peter J; Ikenberg, Kristian; Fuchs, Thomas J; Rechsteiner, Markus; Georgiev, Strahil; Fankhauser, Niklaus; Noske, Aurelia; Roessle, Matthias; Caduff, Rosmarie; Dellas, Athanassios; Fink, Daniel; Moch, Holger; Krek, Wilhelm; Frew, Ian J (2012). p53 suppresses type II endometrial carcinomas in mice and governs endometrial tumour aggressiveness in humans. EMBO Molecular Medicine, 4(8):808-824.

2011

Morra, L; Rechsteiner, M; Casagrande, S; Duc Luu, V; Santimaria, R; Diener, P A; Sulser, T; Kristiansen, G; Schraml, P; Moch, H; Soltermann, A (2011). Relevance of periostin splice variants in renal cell carcinoma. American Journal of Pathology, 179(3):1513-1521.

2008

Rechsteiner, Markus. Function of latent membrane protein 2B in EBV-positive Burkitt's lymphoma. 2008, University of Zurich, Faculty of Science.

This list was generated on Thu Sep 19 10:31:21 2019 CEST.